Cierra N. Sharp

Cierra N. Sharp

May 23, 2016

Group 6 Copy 15
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How oceanographic conditions affect the growth, diet, and survival of juvenile rockfish

    Rockfish are important fishery species on the U.S. West coast. Many rockfish species were overfished in the...

    Monitoring Bird Migration on Monomoy Island

    With the cooperation of US Fish and Wildlife and Monomoy National Wildlife Refuge, Monomoy Bird Observatory...

    Backer Badge Funded